Insider · CIK 0001593084
Linda Marban
Files at CAPR (CAPRICOR THERAPEUTICS, INC.). First filing -, latest -.
Linda Marban files SEC Form 4 as CEO and director at CAPR (CAPRICOR THERAPEUTICS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Linda Marban has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 5, 2026 | CAPR CAPRICOR THERAPEUTICS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Jan 7, 2026 |
| Jan 5, 2026 | CAPR CAPRICOR THERAPEUTICS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +100,000 | $0.00 | $0 | 100,000 | Jan 7, 2026 |
| Jan 5, 2026 | CAPR CAPRICOR THERAPEUTICS, INC. | AGrant or award Restricted Stock Unitsderivative | +7,500 | $0.00 | $0 | 7,500 | Jan 7, 2026 |
| Mar 3, 2025 | CAPR CAPRICOR THERAPEUTICS, INC. | MOption exercise Common Stock | +25,000 | $1.39 | $35k | 223,604 | Mar 5, 2025 |
| Mar 5, 2025 | CAPR CAPRICOR THERAPEUTICS, INC. | JOther Common Stock | -12,500 | $0.00 | $0 | 211,104 | Mar 5, 2025 |
| Mar 3, 2025 | CAPR CAPRICOR THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative | -25,000 | $0.00 | $0 | 0 | Mar 5, 2025 |
| Jan 2, 2025 | CAPR CAPRICOR THERAPEUTICS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +210,000 | $0.00 | $0 | 210,000 | Jan 6, 2025 |
| Jan 2, 2025 | CAPR CAPRICOR THERAPEUTICS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +34,962 | $0.00 | $0 | 34,962 | Jan 6, 2025 |
Questions about Linda Marban
Answered from the filings on this page, as of the latest one.
Is Linda Marban buying or selling?
Linda Marban has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Linda Marban's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Linda Marban has 0.
Where does Linda Marban file Form 4?
Linda Marban has filed Form 4 at CAPR (CAPRICOR THERAPEUTICS, INC.) as CHIEF EXECUTIVE OFFICER. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.